O'Donnell S R, Kay C S
Department of Physiology and Pharmacology, University of Queensland, Brisbane, Australia.
Pulm Pharmacol. 1995 Feb;8(1):11-9. doi: 10.1006/pulp.1995.1002.
IRL 1620 (Suc-[Glu9, Ala11,15]ET-1(8-21), a selective ETB receptor agonist) contracted rat trachea and bronchus. The maximum response to IRL 1620 was less than that to endothelin-1 (ET-1) and, compared with ET-1 responses, IRL 1620 responses reached equilibrium more quickly. IRL 1620 responses were antagonized by the selective ETB antagonist, BQ-788 (3 microM), but not by the selective ETA antagonist, BQ-123 (3 microM). ET-1 concentration-response curves were shifted only in the presence of both BQ-123 and BQ-788 (3 microM). In the presence of BQ-123, the time course of ET-1 responses changed from being slow and sustained (ETA, see below) to being more like that to IRL 1620 (ETB). IRL 1620 did not contract pulmonary artery preparations from rats but ET-1 produced slow and sustained contractile responses which were antagonized by BQ-123 but not by BQ-788. Thus, ET-1 contracts rat pulmonary artery and aorta predominantly via ETA receptors (responses blocked by BQ-123) and functional ETB receptors are unlikely to be present (no responses to IRL 1620). In contrast, ET-1 contracts rat trachea and bronchus via ETA and ETB receptors (tissues contracted to IRL 1620, ET-1 responses were blocked by a combination of BQ-123 and BQ-788 and ET-1 responses resembled ETB in character when ETA receptors were blocked.
IRL 1620(苏氨酸-[谷氨酸9,丙氨酸11,15]内皮素-1(8 - 21),一种选择性ETB受体激动剂)可使大鼠气管和支气管收缩。IRL 1620的最大反应小于内皮素-1(ET-1)的最大反应,并且与ET-1反应相比,IRL 1620反应达到平衡的速度更快。IRL 1620的反应可被选择性ETB拮抗剂BQ-788(3微摩尔)拮抗,但不能被选择性ETA拮抗剂BQ-123(3微摩尔)拮抗。仅在同时存在BQ-123和BQ-788(3微摩尔)时,ET-1浓度-反应曲线才会发生偏移。在存在BQ-123的情况下,ET-1反应的时间进程从缓慢且持续(ETA,见下文)变为更类似于IRL 1620(ETB)的反应。IRL 1620不会使大鼠肺动脉制剂收缩,但ET-1会产生缓慢且持续的收缩反应,该反应可被BQ-123拮抗,但不能被BQ-788拮抗。因此,ET-1主要通过ETA受体使大鼠肺动脉和主动脉收缩(反应被BQ-123阻断),并且不太可能存在功能性ETB受体(对IRL 1620无反应)。相比之下,ET-1通过ETA和ETB受体使大鼠气管和支气管收缩(组织对IRL 1620有收缩反应,ET-1反应被BQ-123和BQ-788联合阻断,并且当ETA受体被阻断时,ET-1反应在特征上类似于ETB)。